LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $470,000 | +10.8% | 3,040 | 0.0% | 0.05% | +20.5% |
| Q3 2021 | $424,000 | +6.3% | 3,040 | 0.0% | 0.04% | +8.3% |
| Q2 2021 | $399,000 | -19.2% | 3,040 | -6.2% | 0.04% | -21.7% |
| Q1 2021 | $494,000 | -5.2% | 3,240 | -38.2% | 0.05% | -8.0% |
| Q4 2020 | $521,000 | +4.4% | 5,240 | 0.0% | 0.05% | -15.3% |
| Q3 2020 | $499,000 | -20.9% | 5,240 | -7.1% | 0.06% | -28.0% |
| Q2 2020 | $631,000 | +22.3% | 5,640 | -20.6% | 0.08% | -9.9% |
| Q1 2020 | $516,000 | -95.7% | 7,100 | -91.9% | 0.09% | -95.3% |
| Q4 2018 | $11,891,000 | -49.5% | 87,630 | +2.2% | 1.94% | -31.6% |
| Q3 2018 | $23,546,000 | +32.8% | 85,782 | +0.2% | 2.84% | +21.6% |
| Q2 2018 | $17,729,000 | +25.2% | 85,577 | -0.2% | 2.34% | +9.8% |
| Q1 2018 | $14,161,000 | -19.2% | 85,742 | -33.0% | 2.13% | -21.9% |
| Q4 2017 | $17,525,000 | -2.9% | 127,987 | -3.4% | 2.73% | -6.1% |
| Q3 2017 | $18,045,000 | +12.4% | 132,537 | +0.2% | 2.90% | +3.6% |
| Q2 2017 | $16,056,000 | +16.8% | 132,257 | +1.8% | 2.80% | +6.2% |
| Q1 2017 | $13,749,000 | +12.4% | 129,905 | +7.9% | 2.64% | +7.3% |
| Q4 2016 | $12,235,000 | +12.2% | 120,409 | +12.7% | 2.46% | +9.7% |
| Q3 2016 | $10,902,000 | -11.9% | 106,820 | +2.9% | 2.24% | -19.0% |
| Q2 2016 | $12,376,000 | +11.6% | 103,762 | +0.2% | 2.77% | +5.1% |
| Q1 2016 | $11,089,000 | -1.1% | 103,545 | +0.1% | 2.63% | -0.1% |
| Q4 2015 | $11,213,000 | +26.8% | 103,420 | +0.2% | 2.64% | +27.1% |
| Q3 2015 | $8,841,000 | -58.7% | 103,220 | -51.3% | 2.07% | -11.4% |
| Q2 2015 | $21,398,000 | +158.1% | 212,070 | +97.2% | 2.34% | +38.4% |
| Q1 2015 | $8,292,000 | +44.0% | 107,535 | -0.6% | 1.69% | +47.4% |
| Q4 2014 | $5,759,000 | +13.2% | 108,235 | -0.0% | 1.15% | +4.8% |
| Q3 2014 | $5,089,000 | -42.2% | 108,289 | -23.5% | 1.09% | -38.1% |
| Q2 2014 | $8,812,000 | -10.1% | 141,471 | -2.9% | 1.77% | -6.8% |
| Q1 2014 | $9,797,000 | -13.5% | 145,641 | -32.3% | 1.90% | -12.1% |
| Q4 2013 | $11,321,000 | +16.3% | 215,223 | -4.3% | 2.16% | +11.3% |
| Q3 2013 | $9,734,000 | -15.0% | 224,904 | -26.5% | 1.94% | -22.0% |
| Q2 2013 | $11,447,000 | – | 306,059 | – | 2.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |